Clinical and laboratory findings in TTP2-7,12
| . | Frequency (%) . |
|---|---|
| Clinical presentation, % | |
| MAHA with thrombocytopenia | 100 |
| Neurological abnormalities | 39-80 |
| Major | 18-53 |
| Minor | 27-42 |
| Fever | 10-72 |
| Gastrointestinal symptoms | 35-39 |
| Renal involvement | 10-75 |
| Classic pentad* | 7 |
| Laboratory findings | |
| Median platelet count, ×109/L | 10-17 |
| Median creatinine, μmol/L | 0.96-1.42 |
| Median LDH, U/L | 1107-1750 |
| Median hematocrit, % | 20-27 |
| . | Frequency (%) . |
|---|---|
| Clinical presentation, % | |
| MAHA with thrombocytopenia | 100 |
| Neurological abnormalities | 39-80 |
| Major | 18-53 |
| Minor | 27-42 |
| Fever | 10-72 |
| Gastrointestinal symptoms | 35-39 |
| Renal involvement | 10-75 |
| Classic pentad* | 7 |
| Laboratory findings | |
| Median platelet count, ×109/L | 10-17 |
| Median creatinine, μmol/L | 0.96-1.42 |
| Median LDH, U/L | 1107-1750 |
| Median hematocrit, % | 20-27 |
LDH, lactate dehydrogenase.
MAHA, thrombocytopenia, neurological abnormalities, fever, and renal dysfunction.